Details for Patent: 11,925,695
✉ Email this page to a colleague
Which drugs does patent 11,925,695 protect, and when does it expire?
Patent 11,925,695 protects DEFINITY and DEFINITY RT and is included in one NDA.
This patent has twenty patent family members in thirteen countries.
Drugs Protected by US Patent 11,925,695
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lantheus Medcl | DEFINITY | perflutren | INJECTABLE;INTRAVENOUS | 021064-001 | Jul 31, 2001 | RX | Yes | Yes | 11,925,695 | ⤷ Subscribe | METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING | ⤷ Subscribe | ||||
| Lantheus Medcl | DEFINITY RT | perflutren | INJECTABLE;INTRAVENOUS | 021064-002 | Nov 17, 2020 | RX | Yes | Yes | 11,925,695 | ⤷ Subscribe | METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,925,695
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2017291815 | ⤷ Subscribe | |||
| Brazil | 112018074469 | ⤷ Subscribe | |||
| Canada | 3025580 | ⤷ Subscribe | |||
| China | 109562194 | ⤷ Subscribe | |||
| China | 116370659 | ⤷ Subscribe | |||
| Eurasian Patent Organization | 201892568 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
